Shui Wang
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
- Pollution top 10%
- Heavy metals in environment
Papers in
- Oncology 11
- Cancer Cells and Metastasis 5
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 2
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Wenbin Zhou (9 shared papers)John P. Giesy (1 shared paper)Peter E. Holm (1 shared paper)Jing Guo (1 shared paper)Binbin Fang (1 shared paper)Wei Shi (1 shared paper)Ge Ma (6 shared papers)Xiaoan Liu (8 shared papers)
- Journals
- Cancer Research (2 papers)Environmental Science & Technology (2 papers)Surgery Today (1 paper)Diagnostic Pathology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited KingdomDenmark
In The Last Decade
Shui Wang
23 papers receiving 463 citations
Peers
Comparison fields: 5 of 98
- Oncology 144
- Pollution 67
- Hematology 33
- Immunology 62
- Cancer Research 42
Countries citing papers authored by Shui Wang
This map shows the geographic impact of Shui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui Wang more than expected).
Fields of papers citing papers by Shui Wang
This network shows the impact of papers produced by Shui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui Wang. The network helps show where Shui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 102 | |
| 2 | 2017 | 62 | |
| 3 | 2020 | 49 | |
| 4 | 2006 | 42 | |
| 5 | 2013 | 42 | |
| 6 | 2018 | 27 | |
| 7 | 2013 | 24 | |
| 8 | 2021 | 20 | |
| 9 | 2015 | 19 | |
| 10 | 2017 | 14 | |
| 11 | 2011 | 13 | |
| 12 | 2012 | 11 | |
| 13 | 2024 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2014 | 6 | |
| 16 | 2023 | 4 | |
| 17 | Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells. | 2002 | 4 |
| 18 | [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients]. | 2004 | 2 |
| 19 | 2020 | 2 | |
| 20 | The significance of serum thymidine kinase 1 on assistant diagnosis and evaluation of chemotherapy effect on breast cancer patients operated | 2010 | 2 |
About Shui Wang
Shui Wang is a scholar working on Oncology, Immunology, Molecular Biology, Environmental Chemistry and Cell Biology, having authored 26 papers that have together received 469 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (2 papers), HER2/EGFR in Cancer Research (2 papers), Cell Adhesion Molecules Research (2 papers), Lymphatic Disorders and Treatments (1 paper) and Neurofibromatosis and Schwannoma Cases (1 paper). The work is most often cited by research in Oncology (144 citations), Pollution (67 citations), Hematology (33 citations), Immunology (62 citations) and Cancer Research (42 citations). Shui Wang has collaborated with scholars based in China, United Kingdom and Denmark. Frequent co-authors include Wenbin Zhou, John P. Giesy, Peter E. Holm, Jing Guo, Binbin Fang, Wei Shi, Ge Ma, Xiaoan Liu, Qiang Ding and Hong Pan. Their work appears in journals such as Cancer Research, Environmental Science & Technology, Surgery Today, Diagnostic Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.